N. Shohat Et Al. , "Alpha-defensin does not provide additional benefit over leukocyte esterase in the diagnosis of periprosthetic joint infection," EXPERT REVIEW OF MOLECULAR DIAGNOSTICS , vol.21, no.8, pp.845-849, 2021
Shohat, N. Et Al. 2021. Alpha-defensin does not provide additional benefit over leukocyte esterase in the diagnosis of periprosthetic joint infection. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS , vol.21, no.8 , 845-849.
Shohat, N., Yacovelli, S., Chisari, E., Clarkson, S., Mann, D., & PARVİZİ, J., (2021). Alpha-defensin does not provide additional benefit over leukocyte esterase in the diagnosis of periprosthetic joint infection. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS , vol.21, no.8, 845-849.
Shohat, Noam Et Al. "Alpha-defensin does not provide additional benefit over leukocyte esterase in the diagnosis of periprosthetic joint infection," EXPERT REVIEW OF MOLECULAR DIAGNOSTICS , vol.21, no.8, 845-849, 2021
Shohat, Noam Et Al. "Alpha-defensin does not provide additional benefit over leukocyte esterase in the diagnosis of periprosthetic joint infection." EXPERT REVIEW OF MOLECULAR DIAGNOSTICS , vol.21, no.8, pp.845-849, 2021
Shohat, N. Et Al. (2021) . "Alpha-defensin does not provide additional benefit over leukocyte esterase in the diagnosis of periprosthetic joint infection." EXPERT REVIEW OF MOLECULAR DIAGNOSTICS , vol.21, no.8, pp.845-849.
@article{article, author={Noam Shohat Et Al. }, title={Alpha-defensin does not provide additional benefit over leukocyte esterase in the diagnosis of periprosthetic joint infection}, journal={EXPERT REVIEW OF MOLECULAR DIAGNOSTICS}, year=2021, pages={845-849} }